Business Wire

Adtran to showcase industry-leading open optical networking for the AI era at OFC 2026

12.3.2026 14:00:00 CET | Business Wire | Press Release

Share

Adtran today announced that it will showcase its latest optical innovations at OFC 2026, taking place from March 15 to 19 in Los Angeles. The company will outline how intelligent, secure and power‑efficient optical networks are shaping the next phase of AI infrastructure.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260311958018/en/

Adtran’s optical networking technology is helping build the foundation for the AI era.

At Adtran’s booth (1001), visitors can explore solutions spanning ultra‑low‑power intra‑data center connectivity, automated open optical transport, access evolution and AI‑enabled operations. Adtran experts will be available throughout the show for conversations and to guide visitors through hands-on demos, as well as leading a range of speaking sessions.

“As AI workloads scale, network operators and cloud providers need an optical foundation that can keep pace with unprecedented demand for capacity and efficiency,” said Christoph Glingener, CTO of Adtran. “Our technology is helping shape the AI era through open, power‑efficient optical architectures and intelligent automation that change the economics of scale. At OFC 2026, we’re demonstrating how operators can boost performance without increasing energy consumption or operational complexity.”

Technology highlights at OFC 2026

At OFC 2026, Adtran will present a broad portfolio of optical networking technologies designed to support scalable, energy‑efficient AI infrastructure across data center, transport and access networks.

  • Ultra‑low‑power 800G connectivity
    LiteWave800™ is a new class of 800Gbit/s pluggable optics for intra‑data center links. Operating at just 1pJ/bit, it sets a new efficiency benchmark for 800Gbit/s connectivity, dramatically reducing power consumption and thermal constraints in dense AI data center fabrics.

  • AI‑enabled operations
    REAL AI will be demonstrated, showing how explainable, AI‑driven automation in network operations empowers operators to improve visibility, accelerate issue resolution and reduce operational complexity.
  • Quantum‑safe networking for critical infrastructure
    The Adtran FSP 3000 S‑Flex™ will be featured, highlighting quantum‑safe optical transport for mission‑critical networks, with ALM fiber assurance shown as a complementary layer for in‑service monitoring, network integrity and detection of physical network intrusion.
  • Open optical transport and interoperability
    Support for open, multi‑vendor optical networking will be highlighted through participation in OIF’s interoperability demo. This will feature Adtran’s 100Gbit/s, 400Gbit/s and 800Gbit/s ZR+ coherent pluggable optics, FSP 3000 open line system with C‑ and L‑band support and Mosaic Network Controller. Adtran’s pluggable optics also feature in related OIF plugfest activities.
  • Access and edge evolution
    Access and aggregation solutions, including 50G PON and innovative edge routing technology, will be shown supporting ultra-scalable, AI-ready services, with automated service‑activation platforms extending intelligence from the core through the door.

Sustainable research and data‑sovereign AI innovation

Beyond its commercial portfolio, Adtran will highlight its leadership in SUSTAINET‑Advance, a European collaborative research initiative focused on building sustainable, resilient and sovereign optical infrastructure.

Adtran is also contributing to demonstrations of the Optical Testbed Data Space (OTDS) in the OFC Demo Zone, showcasing how governed, cross‑domain data sharing can support AI development without exposing sensitive network information.

Together, these initiatives reflect Adtran’s commitment to responsible, standards‑driven innovation and to enabling AI‑ready networks while ensuring operational trust, data sovereignty and long‑term sustainability.

Visit Adtran at OFC 2026

Attendees are invited to visit Booth 1001 to explore Adtran’s technologies and engage with the company’s experts.

Multi‑vendor interoperability demonstrations can also be seen at the OIF booth (2017).

Book a meeting at the show.

About Adtran

ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) is the parent company of Adtran, Inc., a leading global provider of open, disaggregated networking and communications solutions that enable voice, data, video and internet communications across any network infrastructure. From the cloud edge to the subscriber edge, Adtran empowers communications service providers around the world to manage and scale services that connect people, places and things. Adtran solutions are used by service providers, private enterprises, government organizations and millions of individual users worldwide. ADTRAN Holdings, Inc. is also the majority shareholder of Adtran Networks SE, formerly ADVA Optical Networking SE. Find more at Adtran, LinkedIn and X.

Published by
ADTRAN Holdings, Inc.
www.adtran.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20260311958018/en/

Contacts

For media
Gareth Spence
+44 1904 699 358
public.relations@adtran.com

For investors
Peter Schuman
+1 256 963 6305
investor.relations@adtran.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Agenus Reports 48% Estimated Three-Year Survival With BOT+BAL in Recurrent Ovarian Cancer at IGCS 20263.10.2026 16:50:00 CEST | Press Release

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced three-year follow-up results from the ovarian cancer cohort of its 400+ patient Phase 1b C-800-01 trial. The study evaluated botensilimab (BOT), Agenus’ multifunctional, Fc-enhanced anti-CTLA-4 antibody, in combination with balstilimab (BAL), Agenus’ anti-PD-1 antibody. The results, including three-year survival and outcomes by sensitivity to platinum-based chemotherapy and by prior treatment, were presented at the 2026 International Gynecologic Cancer Society (IGCS) Annual Global Meeting in Montréal, Canada. Among patients evaluable for efficacy, three-year overall survival was 48% (n=35), unchanged from the two-year estimate, suggesting durable clinical benefit in this population. Responses and long-term survival were observed in both platinum-sensitive and platinum-resistant or refractory disease. At the last follow-up, 25% of patients who received at least one dose of treatment (11 of 44) were alive

emnify Appoints Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer2.10.2026 17:12:00 CEST | Press Release

emnify, a global leader in IoT connectivity, today announced the appointments of Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer, effective immediately. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261001902751/en/ emnify Appoints Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer The appointments follow the recent naming of Kenneth De Spiegeleire as Chief Executive Officer and Frank Stoecker as Executive Chairman of the Board. Together, these leadership changes strengthen emnify financial, operational, and commercial capabilities as the company enters its next phase of international growth. “We have proven momentum. Our ambition is to now turn it into global category leadership,” said Kenneth De Spiegeleire, CEO of emnify. “That requires sharper focus, disciplined execution, and the right capabilities in the right seats. Sacha brings financial lead

Tacton Appoints Former IFS Executive Merlin Knott as Chief Commercial Officer to Accelerate Global Growth and Scale Beyond CPQ2.10.2026 15:00:00 CEST | Press Release

Tacton, a global leader in Configure, Price, Quote (CPQ) software and configuration solutions for manufacturers of complex products, today announced the appointment of Merlin Knott as Chief Commercial Officer (CCO). In this role, Knott will lead Tacton’s global commercial organization, including marketing, sales, and pre-sales, aligning the teams responsible for bringing Tacton’s solutions to market, and driving value to its customers and partners globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261002794882/en/ Merlin Knott, Chief Commercial Officer, Tacton Knott joins Tacton with decades of experience building and scaling commercial organizations across the enterprise software industry. Most recently, he held senior leadership roles at IFS, the world’s leading provider of Industrial AI software, where he led global partner and channel operations before becoming President of the company’s Enterprise Service Manageme

EDW Presents 2026 Data Quality Award to Repeat Winner Domivest2.10.2026 15:00:00 CEST | Press Release

European DataWarehouse (EDW) presented its fifth annual Data Quality Award at the 2026 TSI Congress in Berlin. This year, EDW's Best Data Quality – Deal of the Year (2026) award was presented to Domivest B.V. for its transaction Domi 2023-1 B.V., recognising the firm's outstanding commitment to accurate, complete, and consistent reporting. The award is based on EDW's proprietary data quality scoring methodology, which evaluates transactions against thousands of validation rules and checks. Data quality excellence is not a one-off achievement. The fact that the same issuers continue to rank among the top performers year after year demonstrates that superior data quality is the result of sustained commitment, robust processes, and ongoing investment. "Receiving the Data Quality Award for a second time means a great deal to us. Transparent, accurate loan-level data is key to investor trust in our transactions, and we are grateful to European DataWarehouse for recognising the work our trea

ILiAD Biotechnologies Expands BPZE1 Public Health and Commercial Potential with Publication of Pediatric Phase 2b Study in The Lancet Infectious Diseases2.10.2026 14:00:00 CEST | Press Release

ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella pertussis, today announced the publication of results from its Phase 2b SUPER (Stand Up to Pertussis) clinical trial in The Lancet Infectious Diseases. This randomized, double blind, placebo- and active-comparator-controlled trial demonstrated that BPZE1, a live attenuated intranasal pertussis vaccine, induced robust nasal mucosal immune responses in healthy children aged 6 through 17 years (LINK). The study demonstrated that a single intranasal dose of BPZE1 induced nasal mucosal immune responses against all Bordetella pertussis antigens tested and was well tolerated, both when administered alone and when co-administered with a tetanus-diphtheria-acellular pertussis (Tdap) booster vaccine. The multi-center Phase 2b trial enrolled 366 participants across 16 sites in the United Kingdom, Australia, and Costa Rica and included participants

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye